OPTOMETRISTS

OPTOMETRISTS Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from OPTOMETRISTS, Medical and health, 720 n cahuenga Boulevard, Los Angeles, CA.

🏥 Collaborating with global healthcare organizations, hospitals, optical enterprises & pharmaceutical partners.
💼 Delivering efficient, compliant medical billing solutions 🇺🇸
For inquiries: optometrists2024@gmail.com

Advice regarding eyecare !
05/08/2026

Advice regarding eyecare !

CORNEAL & LENS RINGS — What Your Eyes May Reveal About Systemic & Ocular DiseaseNot every ring seen in the eye is harmle...
05/08/2026

CORNEAL & LENS RINGS — What Your Eyes May Reveal About Systemic & Ocular Disease

Not every ring seen in the eye is harmless.

Some rings are signs of metabolic disease, some point toward corneal degeneration, while others help diagnose trauma, keratoconus, inflammation, or previous surgery.

For students, clinicians, and eye-care professionals, recognizing these rings can dramatically improve diagnostic accuracy during slit-lamp examination.

Here’s a clinically simplified guide to some of the most important corneal and lens rings 👇

1️⃣ Kayser–Fleischer Ring

A golden-brown or greenish ring caused by copper deposition in Descemet’s membrane.

🔍 Commonly associated with:
• Wilson’s disease
• Systemic copper overload

💡 Clinical pearl:
The ring usually starts superiorly and inferiorly before becoming circumferential. Best visualized on slit lamp examination.

This is one of the classic ocular signs of systemic disease.

2️⃣ Fleischer Ring

An iron deposition ring seen at the base of the cone in keratoconus.

🔍 Seen in:
• Keratoconus

💡 Clinical pearl:
It may appear partial or complete and can help detect early ectatic changes.

Important in contact lens practice and corneal diagnostics.

3️⃣ Arcus Senilis (Corneal Arcus)

A gray-white lipid ring in the peripheral cornea.

🔍 Seen in:
• Aging
• Hyperlipidemia

💡 Clinical pearl:
In elderly patients it is usually benign.
But in younger individuals, it may suggest dyslipidemia or underlying lipid disorders.

4️⃣ Vossius Ring

A ring-shaped pigment imprint on the anterior lens capsule after blunt ocular trauma.

🔍 Seen in:
• Blunt eye injury

💡 Clinical pearl:
It occurs when the iris pigment epithelium strikes the lens during trauma.

A useful clue in ocular trauma assessment.

5️⃣ Wessely Immune Ring

An immune-mediated stromal ring caused by antigen–antibody reactions in the cornea.

🔍 Commonly associated with:
• Microbial keratitis
• Acanthamoeba keratitis
• Herpetic keratitis

💡 Clinical pearl:
This ring represents immune activity rather than direct infection itself.

A very important differentiating sign in corneal infections.

6️⃣ Coats’ White Ring

A small white stromal ring left behind after a healed metallic corneal foreign body.

🔍 Seen in:
• Old corneal foreign body injuries

💡 Clinical pearl:
Usually permanent and clinically insignificant, but indicates prior trauma.

7️⃣ Soemmering’s Ring

Ring-shaped retained lens epithelial material after cataract surgery.

🔍 Seen in:
• Extracapsular cataract extraction

💡 Clinical pearl:
Occurs within the capsular bag and may be discovered incidentally during examination.

8️⃣ Pseudo–Kayser–Fleischer Ring

A ring resembling a true Kayser–Fleischer ring but caused by bilirubin deposition rather than copper.

🔍 Seen in:
• Cholestatic jaundice

💡 Clinical pearl:
Important because it can mimic Wilson’s disease clinically.

👁️ Final Takeaway

The eye is more than a visual organ — it is often a diagnostic window into systemic disease, corneal pathology, trauma, metabolic disorders, and surgical history.

Many of these rings can be detected during a routine slit-lamp examination, making careful observation one of the most powerful clinical skills in eye care.

📚 Exam Mantra:
Think → Pattern → Identify → Syndrome → Treat → Cause

Progressive Lenses Explained — The Science Behind Seamless VisionHave you ever wondered how progressive lenses allow som...
05/08/2026

Progressive Lenses Explained — The Science Behind Seamless Vision

Have you ever wondered how progressive lenses allow someone to see clearly at distance, intermediate, and near — all through a single pair of glasses?

This image demonstrates a modern “Power Map & Visual Fields” design used in premium progressive lenses. It visually represents how lens power gradually changes from the top of the lens to the bottom, creating smooth transitions between viewing distances.

🔍 Understanding the Lens Zones

🔵 Distance Zone (Top Portion)

✔ Driving
✔ Watching TV
✔ Outdoor activities
✔ Classroom or presentations

This area provides the widest and clearest distance field with minimal blur.

🟢 Intermediate Zone (Middle Corridor)

✔ Computer work
✔ Cooking
✔ Dashboard viewing
✔ Conversations

This region is often called the “optical corridor” because it smoothly connects distance and near vision.

🟠 Near Zone (Lower Portion)

✔ Reading
✔ Mobile phone use
✔ Fine detail work
✔ Sewing or paperwork

The bottom section provides additional plus power for near tasks.

📈 What Does the Color Map Mean?

🔹 Blue = Distance power
🔹 Green/Yellow = Intermediate transition
🔹 Red = Maximum near addition power

Unlike bifocals, progressive lenses have NO visible line. The power changes progressively and continuously across the lens surface.

🧠 Why Lens Personalization Matters

Modern premium progressive lenses are customized according to:

✔ Pupillary distance (PD)
✔ Fitting height
✔ Frame shape and tilt
✔ Vertex distance
✔ Facial anatomy
✔ Reading habits
✔ Occupational needs

Benefits include:

✅ Wider visual fields
✅ Faster adaptation
✅ Better peripheral clarity
✅ Reduced swim effect
✅ More natural binocular vision

⚠ Common Adaptation Complaints

Some first-time wearers may experience:

❌ Peripheral distortion
❌ Difficulty using stairs
❌ Head movement adjustment
❌ Mild dizziness initially

Most patients adapt within days to weeks when the fitting is accurate.

💡 Advancement in Progressive Lens Technology

Earlier generations had:

❌ Narrow viewing corridors
❌ Higher unwanted astigmatism
❌ More peripheral blur

Modern digital freeform lenses now provide:

✅ Ultra-wide visual fields
✅ Customized optics for each eye
✅ Enhanced contrast sensitivity
✅ Better night driving performance
✅ Reduced peripheral distortion
✅ Faster adaptation
✅ Wavefront-guided optimization

Some advanced systems even use:

🔹 Artificial intelligence-assisted optimization
🔹 Eye movement tracking
🔹 Lifestyle-based lens algorithms
🔹 Dynamic binocular balancing
🔹 Personalized binocular calculations

👁️ Progressive lenses are no longer just multifocal glasses — they are precision-engineered visual systems designed around the individual wearer.

📌 Clinical Pearl:

Even the best progressive lens can fail if centration and fitting are inaccurate. Proper dispensing is just as important as lens technology.











The Eye as a Living Machine: A Surreal Journey Inside Human Vision(Would you hang this masterpiece in your clinic or off...
05/08/2026

The Eye as a Living Machine: A Surreal Journey Inside Human Vision

(Would you hang this masterpiece in your clinic or office? Tell us below 👁️)

• This extraordinary artwork presents the human eye in a completely different perspective—not merely as an anatomical organ, but as a gigantic living industrial world functioning with perfect coordination and precision.
• Instead of using a traditional medical illustration style, the artist transforms the eye into a futuristic biomechanical city filled with workers, engines, communication hubs, pipelines, support structures, and control centers.
• Every region of the image symbolizes a specific ocular structure and its physiological function, merging science, engineering, and imagination into one complex visual narrative.

• The front transparent region resembles the cornea and anterior chamber, portrayed as the primary gateway where light and external information first enter the system.
• Near the center, circular mechanical rings resemble the iris, ciliary body, and crystalline lens, functioning like advanced optical focusing machinery that regulates and directs incoming visual signals.
• The large reddish-orange spherical structure dominating the image strongly resembles the retina and choroidal vascular network. Here, the artist imagines the retina as an enormous processing district filled with workers, structural beams, fluid channels, and interconnected communication pathways.
• Toward the back, the elongated tunnel-like extension resembles the optic nerve, visualized as a giant transmission highway responsible for carrying visual information toward higher neurological centers.

• The tiny workers distributed throughout the structure symbolize the countless microscopic cellular activities continuously occurring inside the eye.
• These human figures metaphorically represent:
• Photoreceptors detecting light
• Retinal neurons processing images
• Blood vessels supplying nutrients and oxygen
• Neural pathways transmitting information
• Repair and maintenance systems preserving stability
• Support mechanisms maintaining ocular balance and function

• Rather than depicting the eye as a static structure, the artwork portrays vision as the result of an enormous collaborative ecosystem.
• Every component operates like a specialized department within a highly advanced city:
• The “Core Cabin” functions as the central control center.
• The “Visual Module” represents image acquisition and photoreception.
• The “Power Core” symbolizes metabolic and vascular energy supply.
• The “Connection Hub” mirrors neural communication pathways.
• The “Stabilizer Module” reflects mechanisms maintaining alignment and equilibrium.
• The “Outer Armor” resembles the sclera and protective ocular coats shielding delicate internal tissues.

• The extensive motivational slogans and teamwork messages scattered across the image introduce another symbolic layer.
• The artist uses the eye as a metaphor for collective human cooperation, emphasizing that vision itself depends upon perfect synchronization between numerous interconnected systems.
• In this interpretation, the eye becomes more than an organ—it becomes a society, where every structure, pathway, and worker contributes to the greater purpose of perception and awareness.

• Stylistically, the artwork combines multiple disciplines into one unified concept:
• Ocular anatomy
• Visual physiology
• Biomedical illustration
• Mechanical engineering aesthetics
• Futuristic industrial architecture
• Cybernetic worldbuilding
• Human teamwork symbolism

• Overall, the image transforms the human eye into a massive intelligent metropolis of machinery and life, revealing that behind the simple act of seeing exists an incredibly sophisticated universe of coordination, energy, communication, and biological precision.

Gene-Based Retinal Therapy: Teaching the Blind Retina to See AgainFor generations, inherited retinal diseases were consi...
05/07/2026

Gene-Based Retinal Therapy: Teaching the Blind Retina to See Again

For generations, inherited retinal diseases were considered irreversible. Once the retina’s light-sensitive cells died, vision loss was thought to be permanent. Patients diagnosed with conditions like Retinitis Pigmentosa were often told that medicine could slow progression—but could not restore lost sight.

Today, that reality is beginning to change.

Gene-based retinal therapy and optogenetics are opening a completely new chapter in ophthalmology—one focused not only on preservation, but on functional restoration of vision.

This is one of the most groundbreaking areas in modern retinal science.

Understanding the Problem

The retina contains specialized cells called photoreceptors, mainly rods and cones, which convert light into electrical signals sent to the brain.

In inherited retinal diseases such as Retinitis Pigmentosa:

• Photoreceptors gradually degenerate over time
• Night vision worsens first
• Peripheral vision slowly narrows
• Severe cases can eventually lead to profound blindness

For decades, once these cells were lost, there was no way to bring visual function back.

But scientists discovered something remarkable:
Even when photoreceptors die, many deeper retinal cells can remain alive for years.

This raised a revolutionary question:

“What if surviving retinal cells could be taught to detect light themselves?”

What Is Optogenetics?

Optogenetics combines genetics and light-based neuroscience.

Researchers use harmless viral vectors—modified viruses designed specifically for medical treatment—to deliver light-sensitive proteins into surviving retinal cells.

These proteins act like tiny biological light sensors.

After treatment:

• Surviving retinal cells begin responding to incoming light
• The retina partially regains signal transmission capability
• Visual information can once again reach the brain

In simple terms:
Scientists are not replacing the retina.
They are reprogramming remaining cells to take over lost functions.

👉 It is one of the first major attempts to biologically “re-engineer” human vision.

How Does the Therapy Work?

The process generally involves several steps:

• Genetic material carrying light-sensitive proteins is packaged into a harmless viral vector
• The vector is injected into the eye
• Surviving retinal cells absorb the new genetic instructions
• These cells begin expressing proteins capable of responding to light

Some therapies may also use specialized goggles or visual enhancement systems to optimize incoming light signals.

The brain then learns to interpret these new retinal signals over time.

Real Progress in Human Trials

What once sounded like science fiction is now being tested in real patients.

Early human trials have shown encouraging outcomes:

• Some patients regained the ability to detect movement
• Others could identify large objects or navigate spaces more independently
• Functional improvements were observed even in advanced retinal degeneration

One of the most discussed therapies is MCO-010, an investigational optogenetic treatment designed for inherited retinal diseases.

Researchers are optimistic because these approaches may work even when traditional photoreceptors are severely damaged.

Major Milestones in Retinal Gene Therapy

Important moments in the evolution of retinal gene therapy include:

• 2017 – First FDA-approved inherited retinal gene therapy (Luxturna)
• 2020–2023 – Expansion of human optogenetic clinical trials
• 2024–2026 – Increased focus on mutation-specific and personalized retinal therapies

The field is rapidly moving toward precision medicine, where treatment may be customized according to each patient’s exact genetic mutation.

👉 Future retinal care may become highly individualized rather than disease-generalized.

Why This Matters So Much

Inherited retinal diseases affect millions worldwide and often strike people at young ages.

The emotional impact can be devastating:

• Loss of independence
• Difficulty recognizing faces
• Inability to drive
• Progressive isolation from daily activities

Gene therapy introduces something many patients have not heard in years:
Hope.

Not necessarily perfect vision—but useful, functional sight that improves independence and quality of life.

The Challenges Ahead

Although the progress is exciting, several limitations still exist:

• Treatments remain expensive and highly specialized
• Long-term durability is still being studied
• Visual recovery varies between patients
• Advanced disease stages may respond differently

Researchers are continuing to improve safety, resolution, and visual quality with newer generations of therapy.

The Bigger Picture

Gene-based retinal therapy represents a major shift in medicine itself.

Instead of simply treating symptoms, doctors are beginning to modify the biological instructions inside cells.

This means future ophthalmology may increasingly focus on:

• Cellular reprogramming
• Precision genetics
• Regenerative retinal science
• Neural adaptation and brain integration

The retina is becoming one of the most advanced testing grounds for regenerative medicine in the entire human body.

Final Thought

For decades, blindness from inherited retinal disease was viewed as permanent and untreatable.

Today, scientists are teaching surviving retinal cells how to respond to light again.

That single idea has the potential to redefine what blindness means for future generations.

The goal is no longer only preserving what remains.
It is restoring vision where darkness once seemed irreversible.

Diabetic Retinopathy: Understanding the Stages Before Vision is Lost 👁️Diabetic retinopathy is one of the leading causes...
05/07/2026

Diabetic Retinopathy: Understanding the Stages Before Vision is Lost 👁️

Diabetic retinopathy is one of the leading causes of preventable blindness worldwide. What makes it dangerous is that the disease often progresses silently—many patients maintain acceptable vision until retinal damage becomes advanced.

This stage-by-stage retinal comparison highlights how diabetes gradually affects the retinal microvasculature and why early screening is critical.

🔍 What Exactly Happens in Diabetic Retinopathy?

Chronic hyperglycemia damages:
• Retinal capillaries
• Vascular endothelial cells
• Blood-retinal barrier

Over time this leads to:
• Microaneurysms
• Retinal hemorrhages
• Exudates
• Macular edema
• Retinal ischemia
• Neovascularization

The retina essentially suffers from progressive vascular compromise.

📌 Stage 0: Normal Fundus

Features:
• Clear retinal background
• Normal vascular caliber
• Healthy macula and optic disc

👉 This is the baseline every clinician should mentally compare against.

🟡 Stage I: Early Non-Proliferative Diabetic Retinopathy (NPDR)

Typical findings:
• Microaneurysms
• Mild retinal hemorrhages

Patients are often asymptomatic at this point.

👉 Clinical pearl:
This is the stage where screening has the highest preventive value.

🟠 Stage II: Moderate NPDR

Features:
• Increased hemorrhages
• Hard exudates
• Early vascular leakage

Vision may still appear relatively preserved despite ongoing retinal damage.

👉 Important:
Macular involvement determines functional visual loss more than peripheral lesions.

🔴 Stage III: Severe NPDR

Findings may include:
• Extensive hemorrhages
• Cotton wool spots
• Venous beading
• Intraretinal microvascular abnormalities (IRMA)

This stage represents significant retinal ischemia.

👉 High risk:
Patients can rapidly progress to proliferative disease.

⚫ Stage IV: Advanced Retinal Ischemic Changes

Progression causes:
• Worsening capillary non-perfusion
• Increasing retinal hypoxia
• Greater vascular instability

At this stage, VEGF-driven changes become more significant.

👉 Clinical implication:
Close follow-up is mandatory.

🟥 Stage V: Proliferative Diabetic Retinopathy (PDR)

Defining feature:
• Neovascularization

Complications:
• Vitreous hemorrhage
• Fibrovascular proliferation
• Tractional retinal detachment

👉 This is the vision-threatening stage most associated with severe blindness.

🟣 Stage VI: Advanced Complicated Diabetic Retinopathy

May involve:
• Dense vitreous hemorrhage
• Tractional retinal detachment
• Extensive ischemia

Visual prognosis becomes guarded without urgent management.

👉 Surgical intervention may be required:
• PRP
• Anti-VEGF therapy
• Vitrectomy

🟢 Post-Laser Stabilization

The final image demonstrates retinal stabilization after laser photocoagulation.

Purpose of PRP:
• Reduce retinal oxygen demand
• Regress neovascularization
• Prevent severe complications

👉 Important concept:
Laser treatment does not “restore” a normal retina—it stabilizes disease progression.

🧠 Key Clinical Takeaways

• Diabetic retinopathy severity does not always correlate with symptoms
• Early disease can be completely asymptomatic
• Macular edema is the major cause of visual impairment
• Screening is more effective than late intervention
• OCT and fundus photography are essential monitoring tools

💬 For Students & Ophthalmic Professionals

When evaluating diabetic retinopathy, always assess:
• Presence of neovascularization
• Macular involvement
• Extent of ischemia
• Vitreous status
• Tractional components

Don’t just memorize stages—understand the vascular pathophysiology behind them.

📌 Final Thought

Diabetic retinopathy is not merely an eye disease—it is a manifestation of systemic microvascular damage. The retina often reflects years of uncontrolled metabolic stress before symptoms even begin.

Early detection, patient education, and consistent follow-up remain the strongest tools against diabetic blindness.

Which stage do you find most challenging to differentiate clinically: severe NPDR or early PDR? 👇

Follicles on the lower palpebral conjunctiva are most commonly seen in which type of conjunctivitis?A) Viral conjunctivi...
05/07/2026

Follicles on the lower palpebral conjunctiva are most commonly seen in which type of conjunctivitis?
A) Viral conjunctivitis
B) Bacterial conjunctivitis
C) Allergic conjunctivitis

The Retina Revolution: Where Science Meets RegenerationFollow our IG account  for more.For decades, retinal diseases wer...
05/07/2026

The Retina Revolution: Where Science Meets Regeneration

Follow our IG account for more.

For decades, retinal diseases were considered some of the most devastating causes of irreversible blindness. Once retinal cells were damaged, doctors could often do little more than slow the disease down. But in 2026, retinal medicine is entering a completely different era—an era focused not only on preserving sight, but restoring function at the cellular level.

The retina is one of the most complex tissues in the human body. It converts light into electrical signals that the brain interprets as vision. Diseases affecting this delicate structure—such as Retinitis Pigmentosa, Age-Related Macular Degeneration (AMD), and Diabetic Retinopathy—can severely impair quality of life.

Today, however, breakthroughs in genetics, artificial intelligence, light therapy, and biomedical engineering are changing what is possible.

• From treating symptoms → to repairing damaged cells
• From clinic-only care → to continuous home monitoring
• From vision preservation → to potential vision restoration

Here are some of the most exciting retinal innovations shaping the future of eye care.

1. Gene-Based Retinal Therapy

One of the biggest advances in ophthalmology is the rise of gene therapy and optogenetics.

In inherited retinal diseases like Retinitis Pigmentosa, the eye’s photoreceptors gradually die, leading to blindness. Scientists are now developing therapies that deliver light-sensitive proteins into surviving retinal cells using harmless viral vectors.

This means cells that were never designed to detect light can begin responding to it again.

Some early clinical trials have shown patients regaining the ability to perceive movement, detect objects, and navigate environments more independently.

Important milestones include:

• 2017 – First FDA-approved retinal gene therapy (Luxturna)
• 2021 – Expanded optogenetic human trials
• 2026 – Personalized retinal genetic therapies becoming more advanced

The future of retinal medicine may involve tailoring treatment based on each patient’s specific mutation profile.

👉 The goal: restoring functional vision in conditions once considered permanently blinding

2. Photobiomodulation (PBM): Recharging Retinal Cells with Light

Photobiomodulation sounds futuristic, but it is already becoming a reality in retinal care.

Unlike traditional lasers that burn tissue, PBM uses low-level red and near-infrared light to stimulate retinal mitochondria—the energy-producing structures inside cells.

This process may:

• Improve cellular energy production
• Reduce oxidative stress
• Support retinal cell survival
• Improve visual performance in Dry AMD patients

The therapy is painless, non-invasive, and designed to support damaged retinal tissue rather than destroy it.

Recent developments include:

• 2017 – Early PBM retinal research gains attention
• 2023 – FDA-cleared PBM systems for Dry AMD emerge
• 2026 – Expanded clinical interest in retinal regenerative light therapy

Many researchers describe PBM as a way to “recharge” stressed retinal cells before irreversible damage occurs.

👉 The goal: slowing degeneration while improving retinal function naturally

3. Biosimilar Anti-VEGF Injections

Retinal diseases such as Wet AMD and Diabetic Macular Edema often require repeated anti-VEGF injections to prevent blindness.

Drugs like ranibizumab and aflibercept revolutionized retinal treatment, but their high cost created barriers for many patients worldwide.

Now, biosimilar medications are improving accessibility.

Biosimilars are highly comparable versions of original biologic drugs with similar safety and effectiveness but lower cost.

Major developments:

• 2012 – Anti-VEGF therapy becomes standard retinal care
• 2016 – Wider global use of bevacizumab in retinal disease
• 2023–2026 – Multiple retinal biosimilars approved internationally

Benefits include:

• Lower treatment cost
• Increased access in developing countries
• Better patient compliance with long-term therapy
• Reduced healthcare burden globally

👉 The goal: making life-saving retinal treatment available to more patients worldwide

4. Home-Based OCT Monitoring

Optical Coherence Tomography (OCT) transformed retinal diagnostics by allowing doctors to visualize microscopic retinal layers in incredible detail.

Now, OCT technology is moving beyond hospitals and clinics into patients’ homes.

Portable AI-assisted home OCT devices allow patients to monitor their retina regularly without visiting the clinic every week.

These systems can:

• Detect retinal fluid early
• Identify disease recurrence before symptoms appear
• Automatically alert physicians using AI algorithms
• Improve treatment timing and outcomes

Timeline highlights:

• 2018 – AI integration into retinal imaging accelerates
• 2022 – Portable home-OCT prototypes become available
• 2026 – Home retinal monitoring enters broader clinical use

This represents a major shift toward continuous retinal care rather than occasional checkups.

👉 The goal: early detection before vision loss becomes noticeable

The Bigger Transformation

Retinal medicine is rapidly evolving into a field where biology, artificial intelligence, regenerative medicine, and engineering work together.

Researchers are no longer asking:
“How do we slow blindness?”

They are asking:
“How do we restore visual function?”

Future possibilities already being explored include:

• Retinal implants with improved resolution
• AI-guided disease prediction
• Stem-cell retinal regeneration
• Brain-computer visual interfaces
• Autonomous retinal monitoring systems

Only a decade ago, many of these technologies sounded impossible. Today, they are entering clinics, clinical trials, and real-world patient care.

Final Thought

The retina is no longer viewed as a structure that simply degenerates with disease. It is becoming a target for regeneration, restoration, and intelligent monitoring.

The future of retinal care is not just about helping people see longer.
It is about helping people see again.

And for millions living with retinal disease, that future is beginning now.

Vitreous CystFollow our IG account  for more.A 20-year-old male presented with sudden blurring of vision in his left eye...
05/06/2026

Vitreous Cyst

Follow our IG account for more.

A 20-year-old male presented with sudden blurring of vision in his left eye associated with pain on eye movements for the past 4 days. Clinical examination and investigations confirmed acute optic neuritis in the left eye, and appropriate treatment was initiated.

Interestingly, during the dilated fundus examination, an incidental finding was noted in the right eye — an asymptomatic vitreous cyst. The patient had no complaints related to the right eye and was completely unaware of its presence.

Fundus examination revealed an oval-shaped vitreous cyst measuring approximately 1.5 disc diameters in size, showing brownish pigmentation along its margins (Figure A). Ultra-widefield swept-source OCT demonstrated a hyporeflective cavity within the cyst surrounded by a hyperreflective capsule (Figure B, white arrow).

Vitreous cysts are rare ocular findings and may be congenital or acquired. Most remain asymptomatic and are often discovered incidentally during routine retinal evaluation. Advanced retinal imaging such as swept-source OCT helps in detailed characterization of these lesions and differentiating them from other intraocular pathologies.

Phlyctenular keratoconjunctivitis (PKC) is a type of localized, non-infectious inflammation of the eye that typically af...
05/06/2026

Phlyctenular keratoconjunctivitis (PKC) is a type of localized, non-infectious inflammation of the eye that typically affects the conjunctiva and/or cornea. It is considered a hypersensitivity (allergic-type) reaction, most commonly to bacterial antigens.

🔬 What happens in PKC?

Small, raised, white or yellowish nodules called phlyctenules form

Usually located at the limbus (junction of cornea and sclera) or on the conjunctiva

May ulcerate and cause corneal involvement → keratitis

⚠️ Causes / Associations

Most often due to delayed hypersensitivity reaction to:

Staphylococcus aureus (most common, especially in children)

Tuberculosis (TB) (important in endemic areas)

Other bacteria (rare)

Associated conditions:

Blepharitis (lid margin inflammation)

Poor hygiene or chronic infection

Malnutrition (in some populations)

👁️ Symptoms

Redness of the eye

Tearing (watering)

Photophobia (light sensitivity)

Foreign body sensation

Pain (more if cornea involved)

Blurred vision (if corneal ulceration/scarring occurs)

🔎 Signs (on examination)

Small nodular lesion near limbus

Surrounding congestion (redness)

Corneal involvement → ulcer, vascularization

May leave wedge-shaped corneal scar

💊 Treatment

Management focuses on both inflammation control and underlying cause:

1. Anti-inflammatory

Topical steroids (mainstay)

2. Antibiotics

Topical antibiotics (especially for staphylococcal cause)

3. Treat associated conditions

Lid hygiene for blepharitis

Treat TB if suspected (systemic therapy)

4. Supportive care

Lubricating eye drops

⚡ Complications

Corneal ulcer

Scarring → decreased vision

Recurrences if underlying cause persists

🧠 Quick memory tip

Think of PKC as:
👉 “A small immune nodule reacting to bacteria at the edge of the cornea.”

Address

720 N Cahuenga Boulevard
Los Angeles, CA
90038

Website

https://youtube.com/@optometrists2024?si=SUjeSookSQmHSJOn

Alerts

Be the first to know and let us send you an email when OPTOMETRISTS posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Featured

Share